Seaport Global Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,069
Closed -$548K 58
2024
Q1
$548K Hold
16,069
1.11% 37
2023
Q4
$465K Buy
16,069
+8,127
+102% +$235K 1.11% 44
2023
Q3
$219K Buy
7,942
+3,346
+73% +$92.2K 0.66% 55
2023
Q2
$138K Hold
4,596
0.41% 82
2023
Q1
$167K Sell
4,596
-3,431
-43% -$124K 0.53% 79
2022
Q4
$286K Buy
+8,027
New +$286K 0.99% 36